Fahim Abbasi, MD, Senior Research Scientist, Department of Medicine, Stanford University School of Medicine
Research Description: Dr. Abbasi’s research over the past 15 years has focused on role of insulin resistance in the pathophyiology of type 2 diabetes and cardiovascular disease. These research efforts have increased our understanding of how differences in insulin-mediated glucose disposal modulate risk of cardiovascular disease in persons with and without diabetes. Dr. Abbasi has expertise in the gold-standard methods for quantification of insulin-mediated glucose disposal and pancreatic beta cell function in humans, and he collaborates actively and productively with many members of the Stanford DRC.
Selected relevant publications (Stanford DRC members in BOLD):
1. Abbasi F, Kohli P, Reaven GM, Knowles JW: Hypertriglyceridemia: A simple approach to identify insulin resistance and enhanced cardio-metabolic risk in patients with prediabetes. Diabetes Res Clin Pract 2016;120:156-161.
2. Flowers E, Aouizerat BE, Abbasi F, Lamendola C, Grove KM, Fukuoka Y, Reaven GM: Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention. Metabolism 64:1051-1059, 2015.
3. Abbasi F, Blasey C, Feldman D, Caulfield MP, Hantash FM, Reaven GM: Low circulating 25-hydroxyvitamin d concentrations are associated with defects in insulin action and insulin secretion in persons with prediabetes. J Nutr 145:714-719, 2015.
4. Knowles JW, Assimes TL, Tsao PS, Natali A, Mari A, Quertermous T, Reaven GM, Abbasi F: Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp. Metabolism 62:548-553, 2013.
5. Bhat SL, Abbasi FA, Blasey C, Reaven GM, Kim SH: Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults. Metabolism 62:1223-1226, 2013.